Love Data Week was established in 2016. What was originally created in the US quickly grew to an international event in which a wide range of institutions, organizers, scholars, students and data ...

He open-sourced Twitter’s algorithm back in 2023, but then never updated the GitHub. He open-sourced Twitter’s algorithm back in 2023, but then never updated the GitHub. is the Verge’s weekend editor.

But to kick things off, an examination of what's at stake in the final week of the regular season ... The end is near. One more week of the NFL regular season and then everything rises to a different ...

MiniMax Unveils M2.1 to Bring Multilingual Programming Gains to Open AI Models Your email has been sent Chinese AI startup’s release is a major update to its open-source model series, aimed at ...

In my last note on Altimmune, Inc. (ALT) shared in late August, I made the bull case for its stock. I discussed the Gaithersburg, Maryland based biotech's lead and only drug candidate, pemvidutide, ...

Barry Sternlicht's luxury brand 1 Hotels has ditched points for tree-planting and charity donations, betting eco-conscious guests value impact over free stays. The 1 Hotels brand has more than doubled ...

The U.S. government shutdown has continued and is now the longest in history, leaving investors eyeing any developments that could lead to a breakthrough to end the political deadlock. If the shutdown ...

The government shutdown that began Oct. 1 has now become the longest ever, bringing continued disruptions to economic data. With this in mind, key inflation data is expected at the end of next week.

SAN FRANCISCO, Oct 22 (Reuters) - Google said it has developed a computer algorithm that points the way to practical applications for quantum computing and will be able to generate unique data for use ...

We know this will continue the Nod-Krai region Archon Quest storyline. The Fatui are playing a larger role this time around, due to this being near Snezhnaya. Sandrone played a major part in the ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...